THE APEX TIMES
Marlins reliever Andrew Nardi to undergo elbow surgery, ending his 2026 season
Miami manager Clayton McCullough said Andrew Nardi will have elbow surgery, a development that not only closes the left-hander’s year but could carry into the 2027 bullpen picture depending on the procedure’s specifics.
Miami’s bullpen received a major jolt on Monday, when manager Clayton McCullough told reporters that reliever Andrew Nardi will undergo elbow surgery. The decision, as reported, effectively ends Nardi’s 2026 season and introduces uncertainty about his availability beyond this year as the team waits on the full diagnosis and recovery timeline.
Nardi’s injury history already includes a prolonged absence. MLB Trade Rumors noted that he missed all of the 2025 season due to a back injury, making this latest setback a second straight year shaped by health rather than game action.
The Marlins built part of their late-inning depth around pitchers who can handle leverage innings, and Nardi has been in the mix as a left-handed option. With his surgery coming in August, the club now has to plan the remainder of the current year without him while also considering how the bullpen should be structured for the offseason and the start of 2027.
McCullough’s comments were tied directly to the expected impact of the surgery, with the report underscoring that the exact nature of the procedure will determine how far into next season Nardi’s timeline could reach. In practical terms, that means Miami must prepare for at least a near-term void in the left side of the bullpen and possibly a longer one if the elbow requires a more involved recovery.
For Miami, the timing is particularly difficult. An elbow procedure late in a season can force a team to shuffle roles quickly, asking other relievers to absorb innings and leverage assignments they may not have planned to take on when the year began.
The immediate focus for the Marlins will be bullpen workload management and identifying internal solutions. In parallel, the team’s decision-making for the winter could be affected by whether Nardi’s elbow recovery is measured in weeks rather than months, or whether it suggests a longer rebuilding window for that roster slot.
What to watch next is medical detail and official updates on the surgery, including whether any additional steps are required and how the timeline is described after the procedure. For now, the certainty is that Nardi’s 2026 season is over, leaving Miami to re-balance a key relief component as it looks toward 2027.
Why It Matters
- Late-season bullpen injuries can force immediate role changes, increasing pressure on the remaining relievers during critical weeks.
- Because elbow recoveries vary, Nardi’s status could influence Miami’s offseason roster planning and how many relief innings they expect from internal arms versus acquisitions.
- A left-handed late-inning option has specialized value, so losing one can disrupt matchups and leverage planning.
- The overlap with a prior injury absence (missing all of 2025) raises the stakes for how the Marlins manage Nardi’s health moving forward.
Key Facts
- Miami manager Clayton McCullough said Andrew Nardi will undergo elbow surgery.
- The report indicates the surgery will end Nardi’s 2026 season.
- The same report notes that the type of procedure could impact availability next year.
- MLB Trade Rumors reported Nardi missed all of the 2025 season due to a back injury.
- The development affects the Marlins’ bullpen depth, especially on the left side.
- The information was relayed through reporters, with the report tying the update to comments made on Monday.